Loading…

Modulation of miR-26a-5p and miR-15b-5p Exosomal Expression Associated with Clopidogrel-Induced Hepatotoxicity in HepG2 Cells

Clopidogrel is an essential antiplatelet drug used to prevent thrombosis complications associated with atherosclerosis. However, hepatotoxicity is a potential adverse effect related to clopidogrel therapy. Exosome-derived miRNAs may be useful for improved monitoring of drug response and hepatotoxici...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in pharmacology 2017-12, Vol.8, p.906-906
Main Authors: de Freitas, Renata C Costa, Bortolin, Raul H, Lopes, Mariana B, Tamborlin, Letícia, Meneguello, Letícia, Silbiger, Vivian N, Hirata, Rosario D C, Hirata, Mário H, Luchessi, Augusto D, Luchessi, André D
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c462t-2a26c545751dd508aaa72a09b4503740743c4de1c03e06da23feef8d36ff375f3
cites cdi_FETCH-LOGICAL-c462t-2a26c545751dd508aaa72a09b4503740743c4de1c03e06da23feef8d36ff375f3
container_end_page 906
container_issue
container_start_page 906
container_title Frontiers in pharmacology
container_volume 8
creator de Freitas, Renata C Costa
Bortolin, Raul H
Lopes, Mariana B
Tamborlin, Letícia
Meneguello, Letícia
Silbiger, Vivian N
Hirata, Rosario D C
Hirata, Mário H
Luchessi, Augusto D
Luchessi, André D
description Clopidogrel is an essential antiplatelet drug used to prevent thrombosis complications associated with atherosclerosis. However, hepatotoxicity is a potential adverse effect related to clopidogrel therapy. Exosome-derived miRNAs may be useful for improved monitoring of drug response and hepatotoxicity risk. In the present study, the expression of several exosomal miRNAs (miR-26a-5p, miR-145-5p, miR-15b-5p, and miR-4701-3p) and cell-derived mRNA targets ( , and ) were evaluated in HepG2 cells treated with clopidogrel (6.25, 12.5, 25, 50, and 100 μM) for 24 and 48 h. Then, clopidogrel cytotoxicity was evaluated by analyzing DNA fragmentation and the cell cycle profile using flow cytometry. Differential expression of exosome-derived miRNAs and cell-derived mRNAs was analyzed by RT-qPCR. Exposure of HepG2 cells to high concentrations of clopidogrel (50 and 100 μM) for 24 h caused significant DNA fragmentation (17.6 and 44.4%, respectively; < 0.05) and 48 h (26.8 and 48.9%, respectively; < 0.05), indicating cellular toxicity. Upregulation of miR-26a-5p and downregulation of miR-15b-5p was observed in cells exposed to 100 μM clopidogrel for 24 and 48 h. The miR-26a-5p target mRNAs , and were downregulated in HepG2 cells following exposure to cytotoxic concentrations of clopidogrel (50 and 100 μM) for 24 h, and levels remained low after 48 h of treatment. , a target of miR-15b-5p, was downregulated by 50 and 100 μM clopidogrel at 24 h. In conclusion, our results suggest that exposure to high concentrations of clopidogrel modulates the expression of exosomal miR-26a-5p and miR-15b-5p and their target mRNAs in HepG2 cells. Dysregulation of these miRNAs maybe modulate the regulatory pathways involved in clopidogrel-induced liver injury.
doi_str_mv 10.3389/fphar.2017.00906
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_4dfdb6ef7c714aae81a5cd914b3fb58c</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_4dfdb6ef7c714aae81a5cd914b3fb58c</doaj_id><sourcerecordid>1989558357</sourcerecordid><originalsourceid>FETCH-LOGICAL-c462t-2a26c545751dd508aaa72a09b4503740743c4de1c03e06da23feef8d36ff375f3</originalsourceid><addsrcrecordid>eNpVkktv1DAUhS0EotXQPSuUJZsMfifeIFWj0o5UhIRgbd34MeMqEwfbgXbBfyeZKVXrje_rfLbsg9B7gteMteqTH_eQ1hSTZo2xwvIVOidSslq1hL5-Fp-hi5zv8LyYUkzyt-iMKkaIovgc_f0a7dRDCXGooq8O4XtNJdRirGCwx5SIbkmv7mOOB-jnYEwu50VwmXM0AYqz1Z9Q9tWmj2OwcZdcX28HO5m5ceNGKLHE-2BCeajCsFSuabVxfZ_foTce-uwuHvcV-vnl6sfmpr79dr3dXN7WhktaagpUGsFFI4i1ArcA0FDAquMCs4bjhjPDrSMGM4elBcq8c761THrPGuHZCm1PXBvhTo8pHCA96AhBHwsx7TSkEkzvNLfedtL5xjSEA7iWgDBWEd4x34nWzKzPJ9Y4dQdnjRtKgv4F9GVnCHu9i7-1aBjDks-Aj4-AFH9NLhd9CNnMzwGDi1PWRLVKiJbN8yuET6MmxZyT80_HEKwXE-ijCfRiAn00wSz58Px6T4L_X87-AZMyr5k</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1989558357</pqid></control><display><type>article</type><title>Modulation of miR-26a-5p and miR-15b-5p Exosomal Expression Associated with Clopidogrel-Induced Hepatotoxicity in HepG2 Cells</title><source>PubMed Central (Open Access)</source><creator>de Freitas, Renata C Costa ; Bortolin, Raul H ; Lopes, Mariana B ; Tamborlin, Letícia ; Meneguello, Letícia ; Silbiger, Vivian N ; Hirata, Rosario D C ; Hirata, Mário H ; Luchessi, Augusto D ; Luchessi, André D</creator><creatorcontrib>de Freitas, Renata C Costa ; Bortolin, Raul H ; Lopes, Mariana B ; Tamborlin, Letícia ; Meneguello, Letícia ; Silbiger, Vivian N ; Hirata, Rosario D C ; Hirata, Mário H ; Luchessi, Augusto D ; Luchessi, André D</creatorcontrib><description>Clopidogrel is an essential antiplatelet drug used to prevent thrombosis complications associated with atherosclerosis. However, hepatotoxicity is a potential adverse effect related to clopidogrel therapy. Exosome-derived miRNAs may be useful for improved monitoring of drug response and hepatotoxicity risk. In the present study, the expression of several exosomal miRNAs (miR-26a-5p, miR-145-5p, miR-15b-5p, and miR-4701-3p) and cell-derived mRNA targets ( , and ) were evaluated in HepG2 cells treated with clopidogrel (6.25, 12.5, 25, 50, and 100 μM) for 24 and 48 h. Then, clopidogrel cytotoxicity was evaluated by analyzing DNA fragmentation and the cell cycle profile using flow cytometry. Differential expression of exosome-derived miRNAs and cell-derived mRNAs was analyzed by RT-qPCR. Exposure of HepG2 cells to high concentrations of clopidogrel (50 and 100 μM) for 24 h caused significant DNA fragmentation (17.6 and 44.4%, respectively; &lt; 0.05) and 48 h (26.8 and 48.9%, respectively; &lt; 0.05), indicating cellular toxicity. Upregulation of miR-26a-5p and downregulation of miR-15b-5p was observed in cells exposed to 100 μM clopidogrel for 24 and 48 h. The miR-26a-5p target mRNAs , and were downregulated in HepG2 cells following exposure to cytotoxic concentrations of clopidogrel (50 and 100 μM) for 24 h, and levels remained low after 48 h of treatment. , a target of miR-15b-5p, was downregulated by 50 and 100 μM clopidogrel at 24 h. In conclusion, our results suggest that exposure to high concentrations of clopidogrel modulates the expression of exosomal miR-26a-5p and miR-15b-5p and their target mRNAs in HepG2 cells. Dysregulation of these miRNAs maybe modulate the regulatory pathways involved in clopidogrel-induced liver injury.</description><identifier>ISSN: 1663-9812</identifier><identifier>EISSN: 1663-9812</identifier><identifier>DOI: 10.3389/fphar.2017.00906</identifier><identifier>PMID: 29311920</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>clopidogrel ; hepatotoxicity ; HepG2 cell line ; microRNAs ; Pharmacology</subject><ispartof>Frontiers in pharmacology, 2017-12, Vol.8, p.906-906</ispartof><rights>Copyright © 2017 Freitas, Bortolin, Lopes, Tamborlin, Meneguello, Silbiger, Hirata, Hirata, Luchessi and Luchessi. 2017 Freitas, Bortolin, Lopes, Tamborlin, Meneguello, Silbiger, Hirata, Hirata, Luchessi and Luchessi</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c462t-2a26c545751dd508aaa72a09b4503740743c4de1c03e06da23feef8d36ff375f3</citedby><cites>FETCH-LOGICAL-c462t-2a26c545751dd508aaa72a09b4503740743c4de1c03e06da23feef8d36ff375f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733064/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733064/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29311920$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>de Freitas, Renata C Costa</creatorcontrib><creatorcontrib>Bortolin, Raul H</creatorcontrib><creatorcontrib>Lopes, Mariana B</creatorcontrib><creatorcontrib>Tamborlin, Letícia</creatorcontrib><creatorcontrib>Meneguello, Letícia</creatorcontrib><creatorcontrib>Silbiger, Vivian N</creatorcontrib><creatorcontrib>Hirata, Rosario D C</creatorcontrib><creatorcontrib>Hirata, Mário H</creatorcontrib><creatorcontrib>Luchessi, Augusto D</creatorcontrib><creatorcontrib>Luchessi, André D</creatorcontrib><title>Modulation of miR-26a-5p and miR-15b-5p Exosomal Expression Associated with Clopidogrel-Induced Hepatotoxicity in HepG2 Cells</title><title>Frontiers in pharmacology</title><addtitle>Front Pharmacol</addtitle><description>Clopidogrel is an essential antiplatelet drug used to prevent thrombosis complications associated with atherosclerosis. However, hepatotoxicity is a potential adverse effect related to clopidogrel therapy. Exosome-derived miRNAs may be useful for improved monitoring of drug response and hepatotoxicity risk. In the present study, the expression of several exosomal miRNAs (miR-26a-5p, miR-145-5p, miR-15b-5p, and miR-4701-3p) and cell-derived mRNA targets ( , and ) were evaluated in HepG2 cells treated with clopidogrel (6.25, 12.5, 25, 50, and 100 μM) for 24 and 48 h. Then, clopidogrel cytotoxicity was evaluated by analyzing DNA fragmentation and the cell cycle profile using flow cytometry. Differential expression of exosome-derived miRNAs and cell-derived mRNAs was analyzed by RT-qPCR. Exposure of HepG2 cells to high concentrations of clopidogrel (50 and 100 μM) for 24 h caused significant DNA fragmentation (17.6 and 44.4%, respectively; &lt; 0.05) and 48 h (26.8 and 48.9%, respectively; &lt; 0.05), indicating cellular toxicity. Upregulation of miR-26a-5p and downregulation of miR-15b-5p was observed in cells exposed to 100 μM clopidogrel for 24 and 48 h. The miR-26a-5p target mRNAs , and were downregulated in HepG2 cells following exposure to cytotoxic concentrations of clopidogrel (50 and 100 μM) for 24 h, and levels remained low after 48 h of treatment. , a target of miR-15b-5p, was downregulated by 50 and 100 μM clopidogrel at 24 h. In conclusion, our results suggest that exposure to high concentrations of clopidogrel modulates the expression of exosomal miR-26a-5p and miR-15b-5p and their target mRNAs in HepG2 cells. Dysregulation of these miRNAs maybe modulate the regulatory pathways involved in clopidogrel-induced liver injury.</description><subject>clopidogrel</subject><subject>hepatotoxicity</subject><subject>HepG2 cell line</subject><subject>microRNAs</subject><subject>Pharmacology</subject><issn>1663-9812</issn><issn>1663-9812</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkktv1DAUhS0EotXQPSuUJZsMfifeIFWj0o5UhIRgbd34MeMqEwfbgXbBfyeZKVXrje_rfLbsg9B7gteMteqTH_eQ1hSTZo2xwvIVOidSslq1hL5-Fp-hi5zv8LyYUkzyt-iMKkaIovgc_f0a7dRDCXGooq8O4XtNJdRirGCwx5SIbkmv7mOOB-jnYEwu50VwmXM0AYqz1Z9Q9tWmj2OwcZdcX28HO5m5ceNGKLHE-2BCeajCsFSuabVxfZ_foTce-uwuHvcV-vnl6sfmpr79dr3dXN7WhktaagpUGsFFI4i1ArcA0FDAquMCs4bjhjPDrSMGM4elBcq8c761THrPGuHZCm1PXBvhTo8pHCA96AhBHwsx7TSkEkzvNLfedtL5xjSEA7iWgDBWEd4x34nWzKzPJ9Y4dQdnjRtKgv4F9GVnCHu9i7-1aBjDks-Aj4-AFH9NLhd9CNnMzwGDi1PWRLVKiJbN8yuET6MmxZyT80_HEKwXE-ijCfRiAn00wSz58Px6T4L_X87-AZMyr5k</recordid><startdate>20171212</startdate><enddate>20171212</enddate><creator>de Freitas, Renata C Costa</creator><creator>Bortolin, Raul H</creator><creator>Lopes, Mariana B</creator><creator>Tamborlin, Letícia</creator><creator>Meneguello, Letícia</creator><creator>Silbiger, Vivian N</creator><creator>Hirata, Rosario D C</creator><creator>Hirata, Mário H</creator><creator>Luchessi, Augusto D</creator><creator>Luchessi, André D</creator><general>Frontiers Media S.A</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20171212</creationdate><title>Modulation of miR-26a-5p and miR-15b-5p Exosomal Expression Associated with Clopidogrel-Induced Hepatotoxicity in HepG2 Cells</title><author>de Freitas, Renata C Costa ; Bortolin, Raul H ; Lopes, Mariana B ; Tamborlin, Letícia ; Meneguello, Letícia ; Silbiger, Vivian N ; Hirata, Rosario D C ; Hirata, Mário H ; Luchessi, Augusto D ; Luchessi, André D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c462t-2a26c545751dd508aaa72a09b4503740743c4de1c03e06da23feef8d36ff375f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>clopidogrel</topic><topic>hepatotoxicity</topic><topic>HepG2 cell line</topic><topic>microRNAs</topic><topic>Pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>de Freitas, Renata C Costa</creatorcontrib><creatorcontrib>Bortolin, Raul H</creatorcontrib><creatorcontrib>Lopes, Mariana B</creatorcontrib><creatorcontrib>Tamborlin, Letícia</creatorcontrib><creatorcontrib>Meneguello, Letícia</creatorcontrib><creatorcontrib>Silbiger, Vivian N</creatorcontrib><creatorcontrib>Hirata, Rosario D C</creatorcontrib><creatorcontrib>Hirata, Mário H</creatorcontrib><creatorcontrib>Luchessi, Augusto D</creatorcontrib><creatorcontrib>Luchessi, André D</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>de Freitas, Renata C Costa</au><au>Bortolin, Raul H</au><au>Lopes, Mariana B</au><au>Tamborlin, Letícia</au><au>Meneguello, Letícia</au><au>Silbiger, Vivian N</au><au>Hirata, Rosario D C</au><au>Hirata, Mário H</au><au>Luchessi, Augusto D</au><au>Luchessi, André D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Modulation of miR-26a-5p and miR-15b-5p Exosomal Expression Associated with Clopidogrel-Induced Hepatotoxicity in HepG2 Cells</atitle><jtitle>Frontiers in pharmacology</jtitle><addtitle>Front Pharmacol</addtitle><date>2017-12-12</date><risdate>2017</risdate><volume>8</volume><spage>906</spage><epage>906</epage><pages>906-906</pages><issn>1663-9812</issn><eissn>1663-9812</eissn><abstract>Clopidogrel is an essential antiplatelet drug used to prevent thrombosis complications associated with atherosclerosis. However, hepatotoxicity is a potential adverse effect related to clopidogrel therapy. Exosome-derived miRNAs may be useful for improved monitoring of drug response and hepatotoxicity risk. In the present study, the expression of several exosomal miRNAs (miR-26a-5p, miR-145-5p, miR-15b-5p, and miR-4701-3p) and cell-derived mRNA targets ( , and ) were evaluated in HepG2 cells treated with clopidogrel (6.25, 12.5, 25, 50, and 100 μM) for 24 and 48 h. Then, clopidogrel cytotoxicity was evaluated by analyzing DNA fragmentation and the cell cycle profile using flow cytometry. Differential expression of exosome-derived miRNAs and cell-derived mRNAs was analyzed by RT-qPCR. Exposure of HepG2 cells to high concentrations of clopidogrel (50 and 100 μM) for 24 h caused significant DNA fragmentation (17.6 and 44.4%, respectively; &lt; 0.05) and 48 h (26.8 and 48.9%, respectively; &lt; 0.05), indicating cellular toxicity. Upregulation of miR-26a-5p and downregulation of miR-15b-5p was observed in cells exposed to 100 μM clopidogrel for 24 and 48 h. The miR-26a-5p target mRNAs , and were downregulated in HepG2 cells following exposure to cytotoxic concentrations of clopidogrel (50 and 100 μM) for 24 h, and levels remained low after 48 h of treatment. , a target of miR-15b-5p, was downregulated by 50 and 100 μM clopidogrel at 24 h. In conclusion, our results suggest that exposure to high concentrations of clopidogrel modulates the expression of exosomal miR-26a-5p and miR-15b-5p and their target mRNAs in HepG2 cells. Dysregulation of these miRNAs maybe modulate the regulatory pathways involved in clopidogrel-induced liver injury.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>29311920</pmid><doi>10.3389/fphar.2017.00906</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1663-9812
ispartof Frontiers in pharmacology, 2017-12, Vol.8, p.906-906
issn 1663-9812
1663-9812
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_4dfdb6ef7c714aae81a5cd914b3fb58c
source PubMed Central (Open Access)
subjects clopidogrel
hepatotoxicity
HepG2 cell line
microRNAs
Pharmacology
title Modulation of miR-26a-5p and miR-15b-5p Exosomal Expression Associated with Clopidogrel-Induced Hepatotoxicity in HepG2 Cells
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T05%3A26%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Modulation%20of%20miR-26a-5p%20and%20miR-15b-5p%20Exosomal%20Expression%20Associated%20with%20Clopidogrel-Induced%20Hepatotoxicity%20in%20HepG2%20Cells&rft.jtitle=Frontiers%20in%20pharmacology&rft.au=de%20Freitas,%20Renata%20C%20Costa&rft.date=2017-12-12&rft.volume=8&rft.spage=906&rft.epage=906&rft.pages=906-906&rft.issn=1663-9812&rft.eissn=1663-9812&rft_id=info:doi/10.3389/fphar.2017.00906&rft_dat=%3Cproquest_doaj_%3E1989558357%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c462t-2a26c545751dd508aaa72a09b4503740743c4de1c03e06da23feef8d36ff375f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1989558357&rft_id=info:pmid/29311920&rfr_iscdi=true